Ben Halima Afef, Kachboura Salem, Fradi Imen, Bachraoui Kaouther, Mokaddem Aida, Selmi Khalifa, Makni Habib, Boujnah Mohamed Rachid
Service de Cardiologie, Hôpital Mongi Slim, La Marsa.
Tunis Med. 2003 Apr;81(4):217-25.
Over the past decades, the pacemakers have become the standard treatment for patients with symptomatic sinus node disease or high grade atrioventricular block. With the development of pacemaker technology, attempts have been made to apply pacing to the treatment of problems other than symptomatic bradycardia. These problems include pacing to prevent atrial arrhythmia, improve hemodynamic function and to prevent neurocardiogenic syncope. The aim of modern pacing is not only reducing mortality but also improving quality of life and reducing morbidity. Ongoing studies will help to identify better the patient population that benefits most of this treatment.
在过去几十年中,起搏器已成为有症状的窦房结疾病或高度房室传导阻滞患者的标准治疗方法。随着起搏器技术的发展,人们已尝试将起搏应用于有症状心动过缓以外问题的治疗。这些问题包括通过起搏预防房性心律失常、改善血流动力学功能以及预防神经心源性晕厥。现代起搏的目标不仅是降低死亡率,还包括提高生活质量和降低发病率。正在进行的研究将有助于更好地确定最能从这种治疗中获益 的患者群体。